we're not just a stock market game
Sign up free
Amgen Inc (AMGN)
The California-based Amgen is a biotechnology firm that makes drugs aimed at battling anemia, blood disorders, and cancer by attacking the source of the disease - the genes.
DONT BUY THIS!!!! AMGN SUCKS
2 comments so far
+ add yours
kaitlynnkoe
said,
it does suck- 3 months ago
cholox3
said,
yeah dnt buy this, it ffcken suck- about 1 year ago
jsang thinks if Amgen Inc were a historic civilization, it would be Egyptians.
0 comments so far
+ add yours
Events
-
April202012Amgen Inc. expected to report Q1 2012 results on April 20, 2012. This event was calculated by Capital IQ (Created on January 28, 2012).
-
May 72012Amgen Inc. Presents at Deutsche Bank Securities' 37th Annual Health Care Conference, May-07-2012
-
January262013Amgen Inc. expected to report Fiscal Year 2012 results on January 26, 2013. This event was calculated by Capital IQ (Created on January 28, 2012).
Members who own this company also own
$67.11
Current price per share
Today's gain: $-0.95 (-1.40%)
Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
